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Medical informaticsObjective: Pediatric dose rounding is a unique and complex process whose complexity is rarely supported
by e-prescribing systems, though amenable to automation and deployment from a central service pro-
vider. The goal of this project was to validate an automated dose-rounding algorithm for pediatric dose
rounding.
Methods: We developed a dose-rounding algorithm, STEPSTools, based on expert consensus about the
rounding process and knowledge about the therapeutic/toxic window for each medication. We then used
a 60% subsample of electronically-generated prescriptions from one academic medical center to further
reﬁne the web services. Once all issues were resolved, we used the remaining 40% of the prescriptions as
a test sample and assessed the degree of concordance between automatically calculated optimal doses
and the doses in the test sample. Cases with discrepant doses were compiled in a survey and assessed
by pediatricians from two academic centers. The response rate for the survey was 25%.
Results: Seventy-nine test cases were tested for concordance. For 20 cases, STEPSTools was unable to pro-
vide a recommended dose. The dose recommendation provided by STEPSTools was identical to that of the
test prescription for 31 cases. For 14 out of the 24 discrepant cases included in the survey, respondents
signiﬁcantly preferred STEPSTools recommendations (p < 0.05, binomial test). Overall, when combined
with the data from all test cases, STEPSTools either matched or exceeded the performance of the test
cases in 45/59 (76%) of the cases. The majority of other cases were challenged by the need to provide
an extremely small dose. We estimated that with the addition of two dose-selection rules, STEPSTools
would achieve an overall performance of 82% or higher.
Conclusions: Results of this pilot study suggest that automated dose rounding is a feasible mechanism for
providing guidance to e-prescribing systems. These results also demonstrate the need for validating deci-
sion-support systems to support targeted and iterative improvement in performance.
 2013 Elsevier Inc. All rights reserved.1. Introduction
E-prescribing has emerged as a core component of an assumed
safe national healthcare system [1–6]. Federal initiatives such as
the HITECH (Health Information Technology for Economic and
Clinical Health) Act speciﬁcally require the use of e-prescribing
by all medical specialties [7].
However, despite this widespread enthusiasm for e-prescribing,
not all e-prescribing systems support the needs of all specialties. A
recent AHRQ report [8] noted issues of usability with these sys-
tems. There is less data to support the use of e-prescribing in the
ambulatory pediatric community [9], despite the challenges asso-
ciated with pediatric patient medicationmanagement [10]. A study
by Kaushal noted the potential for e-prescribing to prevent up to21% of adverse drug events in outpatient settings, including those
related to drug frequency and weight/dose checks [11].
Pediatric prescribing is a complex process that requires the pre-
scriber to calculate a medication dose that is appropriate for the
treatment goals and for the child’s weight or body surface area
[6]. While some medications are relatively tolerant of inaccurate
dosing, others with narrow therapeutic indices (e.g., Digoxin) have
a great potential for adverse consequences if dosed improperly
[12–14]. This process is sufﬁciently complicated that most pedia-
tricians rely on prescribing guides in print or electronic form to
practice safely [15,16]. Recent advances in medications available
to treat severe conditions also impact children with these condi-
tions [15,17].
One particular area of concern is the lack of sophistication used
when e-prescribing systems automatically calculate doses. Should
a 4.7 kg child receiving 5 mcg/kg/dose of digoxin, totaling
23.5 mcg, receive 0.5 ml (25 mcg, or 10.6 mcg/kg/day) or 0.4 ml
(20 mcg, or 8.51 mcg/kg/day)? Or should the child receive the
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administer at home or require asking for a custom formulation,
which can be expensive?
In the spirit of ‘‘a rising tide lifts all boats,’’ one method to sys-
tematically improve dose-rounding decision support in pediatric e-
prescribing is through the use of cloud-based tools that may be
developed and maintained by knowledge experts and adopted by
all e-prescribing systems with a minimum of effort. This approach
goes by many names, including ‘‘Software as a Service,’’ or web ser-
vices. The goal of this project was to design, develop and evaluate
an algorithm for use in this manner.
2. Methods
2.1. Rounding algorithm
We used a combination of data sources to develop the dosing
algorithm. First, as a part of a previous study, we used literature
about the pharmacokinetic and potential adverse drug event to
develop rounding tolerances for each medication [18]. These
rounding tolerances were combined with the following knowledge
sources to develop a range of allowable doses for each
prescription:
 Medication knowledge (STEPSTools knowledgebase): frequen-
cies of administration, rounding tolerances, minimum and max-
imum daily and per-dose amounts.
 RxNorm, developed by the National Library of Medicine, to pro-
vide a mapping between any string representation of a generic
or brand medication and all dosage forms of that medication.
Finally, we convened a number of expert panels as described in
[18]. Using example prescribing cases to create discussion, pedia-
tricians and pharmacists in these panels provided a number of heu-
ristics they use to create a safe and administrable prescription.
These heuristics became the foundation for selecting an easily
administered dose.
The ﬁnal algorithm for dose selection and rounding prefers as
input the patient’s age in months, the patient’s weight in kilo-
grams, the medication name, and desired mg/kg/day dosing for-
mula. The service also accepts the number of doses per day, a
code for the medication name, and a coding scheme as optional
parameters. Once these data are received, the algorithm goes
through three steps, each of which is discussed below.Fig. 1. STEPSTools dosing algorithm. The dosing process requires 4 steps: looking
up the minimum and maximum allowable dose to create an absolute range;
calculating a relative rounding range based on the weight-based dosing formula
and rounding percentage; combining the two ranges to create a working range
within calculated and allowable doses, and then using heuristics about adminis-
trable doses to select doses within the working range that are easily administered.2.1.1. Data encoding
We use a version of RxNorm concepts distilled into a lookup ta-
ble for all medications in the knowledgebase. This table matches
up the inputted medication name with an RxCUI. If we are unsuc-
cessful in matching the name to a CUI, we query RxNorm using the
RxNorm API. We use this process to improve the performance of
the web service. Once the RxCUI is found, the service retrieves
the medication frequency, absolute minimum dose, maximum
dose, and rounding tolerance.
2.1.2. Dose selecting
Fig. 1 summarizes the key steps in creating a set of safe and
administrable doses. The rounding process requires 4 steps. First,
STEPSTools retrieves information about the minimum and maxi-
mum therapeutic dose from its medication knowledgebase (based
on data from the Harriet Lane Handbook, 18th Edition [19]) to set
the absolute range of doses that can be calculated. Second, STEP-
STools uses patient age and weight information, in addition to pub-
lished formulae forweight-baseddosing and the rounding tolerance
for themedication’s active ingredients to calculate a relative round-
ing range. Third, STEPSTools determines aworking range, taking into
account both the optimal and relative rounding ranges. In cases
where the rounding range is completely within the absolute range,
the relative rounding range is used as the working range; however,
in other cases, STEPSTools defaults the lowestworkingdose to either
the minimum rounded dose or the minimum absolute dose, which-
ever is higher. It performsa similar ﬁlter at thehigh endof thedosing
range if necessary, selecting the lowerdose of the twohighest allow-
able doses. Finally, STEPSTools applies heuristics about homedosing
capabilities to select doses within the working range that are easily
administered. These doses are based on a review of common dosing
implements available through pharmacies. For example, 1 ml syrin-
ges can typically be dosed in 0.1 mL increments, while 10 mL syrin-
ges are easily dosed in increments of 0.5 mL. Most capsules may not
be split, but some pillsmay be. This list of possible doses and formu-
lations within the working range is stored.
2.1.3. Dose recommendation
STEPSTools returns dose recommendations based on the list of
possible doses and dosage forms previously described combined
with heuristics derived from expert panels, which are weighted
using cases from our test suite. The heuristics encompass informa-
tion about the ideal ages for each formulation and the amounts
that are best tolerated by children to score each dosing suggestion,
as described below:
1. If the age of the patient is less than 7 years, and the dose is
in liquid, suppository, or patch, boost the score by 8 points;
if the form is chewable, boost the score by 4 points; if form
is melt away, boost the score by 2 points.
2. If the form is
a. Liquid and
i. The dose is divisible by 0.5 ml, boost by 1 point for patients
7 or older, and 2 points for patients under age 7.
ii. The dose is divisible by 1 ml; add two points for patients 7
or older, and 4 points for patients under age 7.
iii. The volume is less than 10 mL, add one point for patients 7
and older, and 2 points for patients under age 7.
b. Tablet and
i. The dose is divisible by dosage form, add 2 points
1. If the dose quantity is less than 2 tablets, add 2 additional
points.
ii. The dose is not divisible, half the current score (and exclude
if a capsule)
816 K.B. Johnson et al. / Journal of Biomedical Informatics 46 (2013) 814–8213. If the administrable dose is closest to the calculated dose,
add 4 points.
4. If more than one dose has the highest score, break the tie by
adding one point to the dose with the lowest number of
pills or lowest volume of liquid.
In addition, STEPSTools generates a natural language explana-
tion for each score. The entire set of doses and formulations that
are scored are returned to the calling system.2.2. Dosing algorithm analysis
To assess the validity of the dosing algorithm’s responses, we
used a two-part design. First, we created an automated test suite
of cases for each medication. Second, we included cases withdiscrepant doses in a survey distributed to provider subjects. Each
part will be described below.
The test suite of cases consisted of a 6-month sample of elec-
tronically generated prescriptions from one academic center. For
each prescription, we obtained data that would serve as input
parameters (weight, age in months, medication, medication code,
coding scheme, frequency, and mg/kg/day dosing) and data that
would serve as the output validation (formulation, dose, fre-
quency). Prescriptions were excluded if they (1) were generated
for medications not in the STEPSTools knowledge base, (2) were
for patients weighing 60 kg or over (3) were missing the mg/kg/
day rationale needed to calculate a dose. The ﬁnal set of prescrip-
tions was divided randomly into two groups. We used 60% of the
sample chosen at random as the training set, and the remaining
40% as the test set. The training set was used to improve the capa-
bilities of the rounding algorithm and to identify any performance
issues in the web services. For example, initially, the rounding
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ber of tablets or capsules if that dosing instruction would generate
a precise, but intolerable amount of the medication to take. We
used the training set and additional heuristics to improve the
way STEPSTools handles such issues. Once all issues were resolved,
we entered the test cases into our testing suite, which was a toolset
provided by the FitNesse Acceptance Testing Framework (http://
www.ﬁtnesse.org). This tool allows us to put both input and ex-
pected results into a table, then compares the actual results with
the expected results. For the purposes of this test, we considered
the rate at which the highest scoring dose and formulation was
in agreement with the test case, recognizing that the test case’s re-
sult may have been present in the STEPSTools result set in another
position. Any test cases that were not in agreement with the sam-
ple prescription were ﬂagged as discrepant. Test cases included
antibiotics, anti-arrhythmics, diuretics, antipyretics and anti-
inﬂammatory medications.
Discrepant cases were then stratiﬁed by medication name and
incorporated into a survey such that there was one case on the sur-
vey for each medication, ensuring that the survey would include
the minimum number of questions to address the discrepancy.
The 24-item survey was piloted with 10 subjects and then distrib-
uted to a pool of 174 pediatricians at CCHMC and VCH with 111
and 63 providers recruited, respectively. The pool consisted of pro-
viders in General Pediatrics (51%) and specialties in Neurology
(21%) and Cardiology (28%). We received 44 complete responses
after 6 mass email and 3 personalized email reminders over the
course of 3 months, for an overall response rate of 25%. Our ﬁnal
sample consisted of 20 CCHMC and 24 VCH providers with the fol-
lowing self-reported specialties (proportion of our sample shown
in parentheses): General (55%), Neurology (16%), Cardiology
(25%), Internal Medicine (2%), and Hospitalist (2%). Data were col-
lected and managed using REDCap (Research Electronic Data Cap-
ture) tools hosted at Vanderbilt University [20]. REDCap is a secure,
web-based application designed to support data capture for re-
search studies, providing: (1) an intuitive interface for validated
data entry; (2) audit trails for tracking data manipulation and ex-
port procedures; (3) automated export procedures for seamless
data downloads to common statistical packages; and (4) proce-
dures for importing data from external sources. Survey respon-
dents were compensated for their time with a $15 gift card
mailed to their provided mailing addresses. An example question
from the survey (full version available in the Appendix) is shown
below:
2.3. Data analysis
Our team conducted an exploratory analysis of survey data
using R statistical software (http://www.R-project.org). Our unitFig. 2. Test case summary. The set of test cases used in the survey was derived from t
obtained from a set of electronic prescriptions acquired from a cooperating academic med
of cases is shown in parentheses.of analysis was the survey question, with each survey question cor-
responding to a medication. We used a binomial test to determine
whether STEPSTools’ recommendation was chosenmore often than
a non-STEPSTools recommendation (dose originally prescribed for
the test case or an alternative dose provided by the respondent),
i.e., more than 1/3 of the time. If a respondent indicated that s/he
does not prescribe the given medication, his/her response was
not included for that case. Descriptive statistics were used to sum-
marize remaining survey items.3. Results
Fig. 2 summarizes the results of test case selection and analysis.
After creating a candidate set of test cases (8966 cases), we ex-
cluded cases from analyses if they were generated for patients
50 kg or over (n = 1738), were for medications not in the STEP-
STools knowledge base (n = 3714), were missing the mg/kg/day
rationale needed to calculate a dose (n = 3199), or were exact
duplicates of weight, medication and medication dosing strategies
(n = 236). The ﬁnal set included in analyses contained 79 test cases.
As shown in Table 1, there was complete concordance between the
recommended dose/formulation and the prescribed dose/formula-
tion for 31 cases (39% of the 79 test cases). Concordant cases were
from the same categories of medications as discordant cases. Con-
cordance was more likely with tablet or capsule doses, as well as
for medications with fewer possible formulations. The two most
frequent reasons for discordance were related to dose rounding
up to a whole milliliter dose, or selecting a different formulation
from the one that was prescribed. There were 28 cases where STEP-
STools recommended a different formulation or dose than the orig-
inally furnished the test case result (due to rounding up or
rounding down). Four of these cases were excluded from the sur-
vey because they were too similar to cases already included in
the set, i.e., the same medication for the same size child. The
remaining 24 cases were included in the survey distributed to pro-
viders. The ﬂowchart in Fig. 2 shows the derivation of the 24 un-
ique cases used in the survey from the original test set.
Of note, for 20 cases, STEPSTools was unable to generate a
rounded dose. In every case, a recommendation was sought for a
medication for which STEPSTools’ rounding algorithm was unable
to generate an administrable dose within the dosing range because
the dose required was too small (<0.10 mL or mg). For example, in
one case a 5.86 kg, 6-month-old infant, was prescribed lorazepam
at a recommended dose of 0.03 mg/kg/day. STEPSTools attempted
to ﬁnd a dosage form to safely administer a dose between
0.293 mg and 0.30765 mg. Using this dosing range, each adminis-
trable dose is either below the range (0.1 ml = 0.20 mg) or above
the range (0.2 ml = 0.40 mg). Because STEPSTools considers dosinghe 79 test cases included in the STEPSTools concordance experiment, which were
ical center. White boxes indicate cases that were excluded from the survey. Number
Table 1
STEPSTools concordance testing summary. All medication names are shown in generic form for 79 test cases.
Medication Concordance Different amount No recommended dose Different form
Acetaminophen 1
Acyclovir 1
Amitriptyline HCl 1
Amoxicillin trihydrate 1 1
Amoxicillin trihydrate/potassium clavulinate 1
Azathioprine 1
Azithromycin 1 1 1
Calcitriol 1
Carbamazepine 1
Cefdinir 1 1
Cephalexin monohydrate 2
Clarithromycin 1
Clindamycin palmitate 1
Clonazepam 3
Clonidine HCl 4
Diazepam 4 2
Digoxin 1
Divalproex sodium 1
Fluconazole 1
Folic acid 2
Furosemide 1
Hydroxychloroquine sulfate 2
Hydroxyzine HCl 1
Ibuprofen 3 1
Lamotrigine 1
Levetiracetam 4 2
Lisinopril 1
Lorazepam 1 3
Methylphenidate HCl 1 1
Naproxen 1
Ondansetron 1
Oxcarbazepine 2 1 1 1
Prednisolone 1 2
Prednisone 1 1
Propranolol HCl 1 1
Ranitidine HCl 2
Sertraline HCl 1 1
Sulfamethoxazole-trimethoprim 1
Topiramate 1
Zonisamide 1
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dose, although it does return an explanation to explain this logic.
The 24-item survey was piloted with 10 subjects and then dis-
tributed to a pool of 174 pediatricians at CCHMC and VCH with 111
and 63 providers recruited, respectively. The pool consisted of pro-
viders in General Pediatrics (51%) and specialties in Neurology
(21%) and Cardiology (28%). We received 44 complete responses
after 6 email and 3 personalized reminders over the course of
3 months, for an overall response rate of 25%. Our ﬁnal sample con-
sisted of 20 CCHMC and 24 VCH providers with the following self-
reported specialties (proportion of our sample shown in parenthe-
ses): General (55%), Neurology (16%), Cardiology (25%), Internal
Medicine (2%), and Hospitalist (2%).
Overall, the answer proposed by STEPSTools was chosen signif-
icantly more often than either the original provider-furnished an-
swer or a respondent-provided alternative choice in over half of
the cases (58.3% of 24 cases). The ﬁgure below summarizes these
data for each of the 24 survey cases.
In Fig. 3, the frequency of respondents who chose one of four
different recommendations is shown for each survey case. Survey
case numbers and medication names are shown to the left of the
stacked histogram; the number to the right indicates the average
conﬁdence level of the respondents, ranging from 0 (not at all con-
ﬁdent) to 100 (completely conﬁdent). Actual frequencies for each
response are shown embedded in the stacked bar plot. STEPSTools’
recommendations were signiﬁcantly preferred for 14 of the 24
questions with a >80 score of conﬁdence for all but one case (ques-
tion 3, azathioprine). When combined with the data from all testcases, STEPSTools either matched or exceeded the performance of
the test cases in 45/59, or 76% of the cases where it was able to pro-
vide a recommendation.
An analysis of the respondents’ reasons for their preferred rec-
ommendations revealed that the two most popular reasons for
respondents choosing one recommendation over others was
believing there was a better dose amount for weight, or believing
there was a better dosage form for age (see Table 2). Among other
reasons that respondents offered as reasons for their preferred rec-
ommendation, the most common reason was that the preferred
dose is easier for the parent or caretaker to administer.
Based on these results, we were able to identify two additional
rules:
1. if a dose is too small to ﬁnd an admisterable dose within
the working range, select the smallest administerable dose.
2. If there is more than one weight-based dosing strategy
based on indication, run STEPSTools once for each strategy
and include the indication for each as a ﬁeld in the resulting
output.
Adding rule #1 to the STEPSTools algorithm, we found that all
20 excluded cases for which no STEPSTools recommendation was
generated would have resulted in a dose rounded to the minimum
allowable dose consistent with the dosing that was prescribed in
the test case set. This would improve the overall performance to
65/79 cases, or 82%. We identiﬁed an additional 8 excluded cases
that may be impacted by the addition of rule #2.
Frequency
Ca
se
0 10 20 30 40 50
1. Acetaminophen 23435 90.1
2. Amoxicillin 501722 90.2
3. Azathioprine*** 1331 78.2
4. Azithromycin*** 25 5 6 8 83.3
5. Azithromycin 87128 78.3
6. Cefdinir*** 24 8 5 7 85.4
7. Clindamycin Hcl*** 31 1 4 8 85.2
8. Diazepam 818801 85.0
9. Divalproex Sodium*** 021302 87.1
10. Fluconazole 411821 83.1
11. Furosemide 71225 88.5
12. Ibuprofen 179171 86.1
13. Levetiracetam** 52631 88.4
14. Levetiracetam*** 423161 85.3
15. Methylphenidate Hcl* 912941 80.1
16. Naproxen 214325 82.3
17. Ondansetron Hcl 28 2 14 78.1
18. Oxcarbazepine*** 921221 85.0
19. Oxcarbazepine* 03329 86.6
20. Prednisolone*** 26 10 4 4 87.2
21. Prednisolone* 20 11 8 5 83.5
22. Prednisolone 52235 82.3
23. Prednisone*** 29 4 7 4 85.0
24. Sertraline Hcl** 62621 82.6
STEPSTools Provider Other Do Not Prescribe
Fig. 3. Frequencies of responses chosen by survey respondents for each of the 24 test cases. Cases for which STEPSTools’ recommendation was chosen signiﬁcantly more often
than any other recommendation are indicated in the ﬁgure (=p < .05, =p < .01, = p < .001).
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Pediatric dosing is both complex and knowledge intensive. With
the rapid increase in adoption of e-prescribing, developing algo-
rithms to integrate this knowledge into provider decision-making
has the potential to impact the care of children relatively quickly.
However, an important part of making complex services available
is testing the performance of algorithms within these services.
The data above describe both a process of and results related to
testing a dosing algorithm. This testing conﬁrmed our belief that
the STEPSTools rounding algorithm was able to perform well for
many medication cases. Testing also disclosed a number of issues
related to speciﬁc medications, especially issues related to recom-
mending small doses in infants. All these issues appear to be read-
ily addressed. Finally, testing identiﬁed some situations where
STEPSTools’ recommendations were preferred over those of the
test cases.
These results are limited to an analysis of a small dataset from
only one institution, although this institution has one of the largest
outpatient volumes of any pediatric care center. The total number
of usable test cases was signiﬁcantly smaller than we had antici-
pated because the e-prescribing system used to create the data
set did not require mg/kg dosing detail to be provided, challenging
our ability to use many of the cases provided. It is possible that in
many cases where respondents did not prefer STEPSTools’
recommendation even though the STEPSTools algorithm
performed correctly, respondents might have chosen STEPSTools’
recommendations had we provided the explanation for the se-
lected dose. For example, in case #10, STEPSTools did not recom-
mend the dose amount of 80 mg that was provided by our test
data set, because according to its algorithm, the minimum dose
for age should have been 148 mg/dose. We elected not to presentthese explanations on the survey, so that we could preserve the
blinding of which dose was manually versus automatically
calculated.
STEPSTools did not make recommendations for a number of
medications where minute doses were required. Part of the chal-
lenge with these small dose calculations relates to the inferences
that can be made on the part of the algorithm. For example, clo-
nidine is a medication often used to treat hypertension in infants
and falls into the class of medications whose dosing is related to
avoiding toxicity related to hypotension.[18] Although the pub-
lished dosing is between 5 and 10 mcg/kg/day divided into four
doses daily, it would be incorrect to assume that ‘‘sliding’’ the
dose beyond whatever integer option was selected by the pre-
scriber would always be acceptable, because of the known risks
of overdosing (e.g., rounding 6 mcg/kg/day up to 7 mcg/kg/day
automatically) Therefore, in designing our dosing algorithm, we
did not take into account the option the prescriber has to select
a higher therapeutic dose if STEPSTools cannot ﬁnd a dose within
the rounding tolerance for the chosen dosing that can be admin-
istered in a 1/10th ml volume. In reality, most prescribers would
likely round up to the nearest 1/10th ml regardless of the round-
ing tolerance (as was described in Section 3), or the patient would
be prescribed an extemporaneously compounded (and less con-
centrated) formulation that allows for an easier to administer
dose. This sort of tradeoff was actively discussed by our team of
developers, pharmacist experts, and pediatricians during develop-
ment. After reviewing training data, we elected to err on the side
of not providing a choice outside of the rounding tolerance, pend-
ing the results of this analysis. Results from our study suggest
that additional reﬁnements to the existing algorithm may be war-
ranted to examine safe ways to provide recommendations for
small dose cases.
Table 2
Frequency table of reasons indicated by respondents for their preferred recommendation. Modes are indicated in bold. Other reasons shown in the left-most column are free-texted responses offered by respondents who chose ‘Other
reason’ categorized by the type of reason.
Case Better dose amt. for
age
Better dose amt. for
weight
Better dosage form for
age
Better dosage form for
weight
Other Other reasons
1 (Acetaminophen) 0 27 3 9 3 Easier to administer, easier to calculate
2 (Amoxicillin) 2 23 6 6 2 Standard recommendation, insufﬁcient information*
3 (Azathioprine) 0 1 5 7 0 N/A
4 (Azithromycin) 3 14 3 9 7 Easier to administer, Standard recommendation
5 (Azithromycin) 2 6 21 4 3 Insufﬁcient information*, standard recommendation
6 (Cefdinir) 1 10 6 11 9 Easier to administer, Better dose frequency, insufﬁcient information*
7 (Clindamycin HCl) 3 17 1 9 6 Easier to administer
8 (Diazepam) 0 6 10 8 2 Easier to administer
9 (Divalproex sodium) 0 2 17 4 1 Better dosage form overall
10 (Fluconazole) 10 5 8 5 2 Easier to administer
11 (Furosemide) 3 6 6 8 4 Easier to administer, easier to calculate
12 (Ibuprofen) 1 6 22 7 7 OTC available for concentration
13 (Levetiracetam) 2 0 11 3 3 Easier to administer, insufﬁcient information*
14 (Levetiracetam) 0 0 16 1 3 Better dose frequency
15 (Methylphenidate
HCl)
2 1 14 4 4 Better dose frequency
16 (Naproxen) 1 24 1 4 2 Insufﬁcient information*
17 (Ondansetron) 3 12 6 3 6 Easier to administer, insufﬁcient information*
18 (Oxcarbazepine) 2 4 2 3 4 Easier to administer, better dose frequency
19 (Oxcarbazepine) 0 1 8 2 3 Better dose frequency, insufﬁcient information*
20 (Prednisolone) 2 16 5 6 11 Easier to administer
21 (Prednisolone) 4 10 10 7 8 Easier to administer, standard concentration
22 (Prednisolone) 2 4 25 5 3 Better dosage form overall, easier to administer, insufﬁcient
information*
23 (Prednisone) 3 11 9 10 7 Easier to administer
24 (Sertraline HCl) 1 1 10 3 3 Easier to administer
* Insufﬁcient information includes: dose depends on indication, dose depends on the individual.
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that errors may be introduced when humans modify automati-
cally calculated doses in e-prescribing systems [21]. It was our
hope that STEPSTools would be able to recommend one and only
one dose for each scenario. However, as is evident from our sur-
vey data, and as we discovered innumerable times during the
training phase of this project (leading to some of our heuristics
for weighting a dose) there are numerous equally safe doses,
especially when generic forms of medications come in a variety
of formulations. Which dose to select may be based on child
and family preferences regarding the dosage form (liquid versus
tablet/capsule), the dosing volume strategy (larger volume of bet-
ter tasting or easy-to-administer medications), and even the fre-
quency of administration (more frequent dosing may lead to
less physiologic ﬂuctuations, for example). Therefore, it is clear
that a more customized user experience may involve using the
same dosing algorithm to generate a small set of potential dosing
strategies based on a palette of preferences. In the absence of
information about personal preferences, algorithms for dose
rounding, drug selection, or other decisions that rely on these
preferences should simply provide this subset, along with explan-
atory text that differentiates each option. This approach would al-
low a series of safe doses to be ‘‘selectable’’ by the user, thereby
avoiding errors, such as misplaced decimal points or ambiguous
dosing instructions to be entered.
Future work in this area will undoubtedly focus on these chal-
lenges, as well as the challenge of developing safe and usable ways
to exploit the range of dosing formulae, as noted above. Future
work also will need to increase the number of medications in-
cluded in the STEPSTools rounding knowledgebase to support both
pediatric and common adult liquid outpatient medications, given
the potential for this algorithm to help with outpatient dosing of
liquid formulations in any age group.Acknowledgments
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